ELI LILLY AND CO.

Remarks in House

Pharmaceuticals: decision by manufacturers to cap patient out-of-pocket costs for insulin, H1535 [29MR]

Remarks in Senate

Pharmaceuticals: decision by manufacturers to cap patient out-of-pocket costs for insulin, S616 [2MR], S645 [6MR], S756 [14MR], S810 [16MR]